[go: up one dir, main page]

ES2075860T3 - Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion. - Google Patents

Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion.

Info

Publication number
ES2075860T3
ES2075860T3 ES90115961T ES90115961T ES2075860T3 ES 2075860 T3 ES2075860 T3 ES 2075860T3 ES 90115961 T ES90115961 T ES 90115961T ES 90115961 T ES90115961 T ES 90115961T ES 2075860 T3 ES2075860 T3 ES 2075860T3
Authority
ES
Spain
Prior art keywords
salts
pirazolo
optically active
alcoxi
triazinas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90115961T
Other languages
English (en)
Inventor
Kinji Hashimoto
Masatoshi Inai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2075860T3 publication Critical patent/ES2075860T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION EXPONE UNA SAL ELEGIDA DEL GRUPO CONSISTENTE EN SALES DE METALES ALCALINOS Y ALCALINOTEREOS EN FORMA ACTIVA OPTICAMENTE A PARTIR DE UN 4-HIROXI-8(3-INFERIOR ALCOXI-4-FUEL SULFINILFENIL) PIRAZOLO [1,5-A] -1,3,5-TRIAZINA; Y UN PROCESO PARA PRODUCIR DICHOS COMPONENETES Y SUS SALES ASI COMO UNA COMPOSICION FARMACEUTICA, QUE COMPRENDE UNA CANTIDAD EFECTIVA DE LA SAL JUNTO CON UN PORTADOR NO TOXICO ACEPTABLE FARMACEUTICAMENTE
ES90115961T 1989-08-25 1990-08-21 Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion. Expired - Lifetime ES2075860T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21918189 1989-08-25
JP2179852A JP2691317B2 (ja) 1989-08-25 1990-07-06 ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法

Publications (1)

Publication Number Publication Date
ES2075860T3 true ES2075860T3 (es) 1995-10-16

Family

ID=26499580

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90115961T Expired - Lifetime ES2075860T3 (es) 1989-08-25 1990-08-21 Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion.

Country Status (10)

Country Link
US (1) US5137887A (es)
EP (1) EP0414200B1 (es)
JP (1) JP2691317B2 (es)
KR (1) KR960002851B1 (es)
CN (1) CN1028528C (es)
AU (1) AU630489B2 (es)
CA (1) CA2023430C (es)
DE (1) DE69021296T2 (es)
DK (1) DK0414200T3 (es)
ES (1) ES2075860T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR927003595A (ko) * 1990-10-09 1992-12-18 오츠카 아키히코 피리미딘 유도체, 이의 제조방법 및 안드로겐 저해제
EP0599647B1 (en) * 1992-11-27 1997-02-05 Sumitomo Special Metals Co., Ltd. Production method of a rare earth-iron-nitrogen system permanent magnet
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
NZ333777A (en) * 1996-07-24 2000-07-28 Du Pont Pharm Co (1,5-a) pyrazolo and triazole triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
AU4331500A (en) * 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
AU4203500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
MXPA02002111A (es) * 1999-08-27 2002-10-31 Abbott Lab Compuestos de sulfonilfenilpirazol utiles como inhibidores de cox-2.
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
US7329658B2 (en) * 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7153961B2 (en) * 2003-11-25 2006-12-26 Bristol-Myers Squibb Pharma Co. Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
EP1757610B1 (en) * 2004-06-14 2011-06-08 Nippon Chemiphar Co., Ltd. Condensed pyrimidine derivative and xanthine oxidase inhibitor
EP1911760A4 (en) * 2005-07-01 2010-06-02 Nippon Chemiphar Co xanthine oxidase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds

Also Published As

Publication number Publication date
AU6098590A (en) 1991-02-28
DE69021296D1 (de) 1995-09-07
CA2023430C (en) 1997-11-11
EP0414200B1 (en) 1995-08-02
DK0414200T3 (da) 1995-12-27
KR910004623A (ko) 1991-03-29
CN1049664A (zh) 1991-03-06
EP0414200A2 (en) 1991-02-27
CA2023430A1 (en) 1991-02-26
JP2691317B2 (ja) 1997-12-17
DE69021296T2 (de) 1996-02-01
KR960002851B1 (ko) 1996-02-27
US5137887A (en) 1992-08-11
CN1028528C (zh) 1995-05-24
EP0414200A3 (en) 1991-11-13
AU630489B2 (en) 1992-10-29
JPH03163082A (ja) 1991-07-15

Similar Documents

Publication Publication Date Title
ES2075860T3 (es) Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion.
ES2099758T3 (es) Procedimiento para preparar catalizadores para polimerizacion por adicion mediante oxidacion del nucleo metalico.
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
AR245706A1 (es) Compuestos de benzoilurea, procedimiento para su produccion, composiciones plaguicidas que los contienen e intermediarios.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
ES2132580T3 (es) Derivados de aroil-piperidina.
ES2188604T3 (es) Inhibidores de proteasa del vih en combinaciones farmaceuticas para eltratamiento del sida.
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
ES8305351A1 (es) Procedimiento para la preparacion de derivados de isoquino- leina
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
ES2000502A6 (es) Un procedimiento para la preparacion de poli-4-aminopirrol-2-carboxamido derivados
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2054729T3 (es) Derivados de pirrolidina.
ES8304978A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ES8404658A1 (es) Metodo y aparato para orientar y alimentar articulos, en particular piezas en bruto para tapones-capsula de cierre.
FR2766183B1 (fr) Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
UY23103A1 (es) Composicion biocida y procedimiento para su fabricacion
ES2062782T3 (es) Capsula oleaginosa de cetoprofeno.
NO990159D0 (no) FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer
ES8504725A1 (es) Procedimiento para preparar los antipodas opticos de 8-amino-2-metil-4-fenil-1, 2, 3, 4-tetrahidroisoquinoleina
HUT46535A (en) Process for producing antidepressive pharmaceutical compositions

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414200

Country of ref document: ES